Gilder Gagnon Howe & Co’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.47M | Buy |
129,571
+23,754
| +22% | +$270K | 0.02% | 189 |
|
2025
Q1 | $704K | Buy |
105,817
+13,271
| +14% | +$88.3K | 0.01% | 196 |
|
2024
Q4 | $1.02M | Buy |
92,546
+1,791
| +2% | +$19.8K | 0.01% | 210 |
|
2024
Q3 | $1.12M | Buy |
90,755
+2,178
| +2% | +$26.8K | 0.01% | 204 |
|
2024
Q2 | $1.2M | Sell |
88,577
-1,206
| -1% | -$16.3K | 0.02% | 198 |
|
2024
Q1 | $1.21M | Buy |
89,783
+27,535
| +44% | +$372K | 0.02% | 206 |
|
2023
Q4 | $327K | Sell |
62,248
-11
| -0% | -$58 | ﹤0.01% | 233 |
|
2023
Q3 | $245K | Buy |
62,259
+11,185
| +22% | +$44.1K | ﹤0.01% | 246 |
|
2023
Q2 | $543K | Sell |
51,074
-863
| -2% | -$9.17K | 0.01% | 245 |
|
2023
Q1 | $433K | Buy |
51,937
+29,333
| +130% | +$244K | 0.01% | 225 |
|
2022
Q4 | $209K | Sell |
22,604
-35,260
| -61% | -$325K | ﹤0.01% | 236 |
|
2022
Q3 | $743K | Sell |
57,864
-445
| -0.8% | -$5.71K | 0.01% | 207 |
|
2022
Q2 | $770K | Sell |
58,309
-506,207
| -90% | -$6.68M | 0.01% | 209 |
|
2022
Q1 | $11.9M | Sell |
564,516
-507,924
| -47% | -$10.7M | 0.11% | 128 |
|
2021
Q4 | $25.7M | Sell |
1,072,440
-50,915
| -5% | -$1.22M | 0.15% | 126 |
|
2021
Q3 | $28.6M | Sell |
1,123,355
-122,601
| -10% | -$3.12M | 0.15% | 133 |
|
2021
Q2 | $41.9M | Sell |
1,245,956
-19,994
| -2% | -$673K | 0.21% | 113 |
|
2021
Q1 | $49.2M | Sell |
1,265,950
-204,891
| -14% | -$7.96M | 0.27% | 101 |
|
2020
Q4 | $91.1M | Sell |
1,470,841
-19,312
| -1% | -$1.2M | 0.45% | 70 |
|
2020
Q3 | $49.9M | Sell |
1,490,153
-79,411
| -5% | -$2.66M | 0.31% | 90 |
|
2020
Q2 | $37.4M | Sell |
1,569,564
-117,183
| -7% | -$2.79M | 0.29% | 90 |
|
2020
Q1 | $38.6M | Sell |
1,686,747
-140,143
| -8% | -$3.21M | 0.46% | 71 |
|
2019
Q4 | $51.7M | Sell |
1,826,890
-49,301
| -3% | -$1.4M | 0.54% | 66 |
|
2019
Q3 | $40.3M | Buy |
1,876,191
+14,568
| +0.8% | +$313K | 0.46% | 68 |
|
2019
Q2 | $54.3M | Buy |
+1,861,623
| New | +$54.3M | 0.55% | 63 |
|